Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

NCT01093235 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

800

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Cardiac Toxicity
Perioperative/Postoperative Complications

Interventions

BIOLOGICAL: bevacizumab
DRUG: cyclophosphamide
DRUG: docetaxel
DRUG: epirubicin hydrochloride
DRUG: fluorouracil
PROCEDURE: assessment of therapy complications
PROCEDURE: neoadjuvant therapy
PROCEDURE: quality-of-life assessment
PROCEDURE: therapeutic conventional surgery

Sponsor

Cambridge University Hospitals NHS Foundation Trust